L-carnitine 1000 Mg

DRUG2 trials

Sponsors

Royan Institute, Darya Chamani

Conditions

End-stage Renal Disease (ESRD)HemodialysisPolycystic Ovary Syndrome

Phase 2

Oral L-carnitine and Inflammatory and Nutritional Biomarkers in Maintenance Hemodialysis

CompletedNCT07249229

Darya ChamaniEnd-stage Renal Disease (ESRD), Hemodialysis

Start: 2020-11-30End: 2021-03-08Updated: 2025-12-19

Unknown Phase

L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles

CompletedNCT04672720

Royan InstitutePolycystic Ovary Syndrome

Start: 2020-03-01End: 2023-02-28Updated: 2023-06-18

Related Papers

Adding L-carnitine to antagonist ovarian stimulation doesn’t improve the outcomes of IVF/ ICSI cycle in patients with polycystic ovarian syndrome: a double-blind randomized clinical trial

Journal of Ovarian Research2024-01-091 citations